What's new! CIDG publications February 2022

During February 2022, we published one protocol and one new review in Issue 2, 2022 of the Cochrane Database of Systematic Reviews.

New Protocol

Crider KS, Williams JL, Qi YP, Gutman J, Yeung LF, Mai CT, Finkelstein JL, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers LM, Daniels K, Green P. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database of Systematic Reviews 2022, Issue 2. Art. No.: CD014217. DOI: 10.1002/14651858.CD014217.


New Review

Taylor M, Thomas R, Oliver S, Garner P. Community views on mass drug administration for filariasis: a qualitative evidence synthesis. Cochrane Database of Systematic Reviews 2022, Issue 2. Art. No.: CD013638. DOI: 10.1002/14651858.CD013638.pub2.


Read the LSTM news story here. 

Throughout 2022, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter:




The CIDG editorial base is located at the
 Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals